NeuroAIDS: diagnosis and management.
Neurologic disorders are present in 15% to 30% of AIDS patients. The physiologic isolation imposed by the brain and blood-brain barrier have limited characterization of the disorders and assessment of therapy. Only time will tell whether the multidrug antiretroviral regimens that have shown such success in controlling HIV in the systemic compartment will be equally effective in suppressing brain viremia.
McArthur
J C
JC
Johns Hopkins University, Baltimore, USA.
D015526:AIDS Dementia Complex / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D004359:Drug Therapy, Combination; D015497:HIV-1; D006801:Humans; D008279:Magnetic Resonance Imaging; D009422:Nervous System Diseases / Q000175:diagnosis* / Q000188:drug therapy; D011569:Psychiatric Status Rating Scales
D019380:Anti-HIV Agents